Inflammatory Cytokine Tumor Necrosis Factor α Confers Precancerous Phenotype in an Organoid Model of Normal Human Ovarian Surface Epithelial Cells
article
OA: gold
CC0
⤵ 1 in-corpus citation
AI-generated summary
Tumor necrosis factor alpha treatment of normal human ovarian surface epithelial cell organoids induced precancerous characteristics, including proliferation, invasion, and altered morphology.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
In this study, we established an in vitro organoid model of normal human ovarian surface epithelial (HOSE) cells. The spheroids of these normal HOSE cells resembled epithelial inclusion cysts in human ovarian cortex, which are the cells of origin of ovarian epithelial tumor. Because there are strong correlations between chronic inflammation and the incidence of ovarian cancer, we used the organoid model to test whether protumor inflammatory cytokine tumor necrosis factor alpha would induce malignant phenotype in normal HOSE cells. Prolonged treatment of tumor necrosis factor alpha induced phenotypic changes of the HOSE spheroids, which exhibited the characteristics of precancerous lesions of ovarian epithelial tumors, including reinitiation of cell proliferation, structural disorganization, epithelial stratification, loss of epithelial polarity, degradation of basement membrane, cell invasion, and overexpression of ovarian cancer markers. The result of this study provides not only an evidence supporting the link between chronic inflammation and ovarian cancer formation but also a relevant and novel in vitro model for studying of early events of ovarian cancer.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer 2007
- Precursor lesions of ovarian epithelial malignancy 2001
Cited by (1)
References (62)
- Precursor lesions of ovarian epithelial malignancy via openalex
- Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer via openalex
- W1585093254 via openalex
- W1598770549 via openalex
- W1763490035 via openalex
- W1867329951 via openalex
- W1970336778 via openalex
- W1977354546 via openalex
- W1980039397 via openalex
- W1988841986 via openalex
- W1993230971 via openalex
- W1993539263 via openalex
- W1994927392 via openalex
- W1999981141 via openalex
- W2002387315 via openalex
- W2004239490 via openalex
- W2005020146 via openalex
- W2005113853 via openalex
- W2010317565 via openalex
- W2024354916 via openalex
- W2026908726 via openalex
- W2031213790 via openalex
- W2042774683 via openalex
- W2044341880 via openalex
- W2048325240 via openalex
- W2052042061 via openalex
- W2054696173 via openalex
- W2057123987 via openalex
- W2059143304 via openalex
- W2060626200 via openalex
- W2062333398 via openalex
- W2065036320 via openalex
- W2076816261 via openalex
- W2077065757 via openalex
- W2083473828 via openalex
- W2086087207 via openalex
- W2090702820 via openalex
- W2098050793 via openalex
- W2103815419 via openalex
- W2107277218 via openalex
- W2123937928 via openalex
- W2124374247 via openalex
- W2132286891 via openalex
- W2133439754 via openalex
- W2138202356 via openalex
- W2144116189 via openalex
- W2144420811 via openalex
- W2144737008 via openalex
- W2154951555 via openalex
- W2164394800 via openalex
- W2167096402 via openalex
- W2414301030 via openalex
- W4211081176 via openalex
- W4232845922 via openalex
- W4323966335 via openalex
- W6630230756 via openalex
- W6630760116 via openalex
- W6637828075 via openalex
- W6678502572 via openalex
- W55919682 via openalex
- W6680423876 via openalex
- W1512707729 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK